Literature DB >> 2707551

Two different types of antimitochondrial antibodies (anti-M2 and anti-M4) may not differentiate primary biliary cirrhosis (PBC) with prominent piecemeal necrosis from classical PBC.

T Okuno1, M Shindo, M Matsumoto, K Arai, M Takeda, M Iwai, T Nakashima, T Takino.   

Abstract

Clinical and morphological features in 13 patients with primary biliary cirrhosis (PBC) who had two different types of antimitochondrial antibodies (PBC-specific, anti-M2 and mixed-form, anti-M4) in serum tested, were studied. Patients were allocated to two groups purely on the basis of the presence or absence of prominent piecemeal necrosis (PN) to elucidate the clinical significance of PN for differentiating mixed forms of chronic active hepatitis and PBC from classical PBC. Histological staging showed 10 stage I and 3 stage II. All cases had histological features of chronic non-suppurative destructive cholangitis. Prominent PN was encountered in 8 and bridging hepatic necrosis in 6. Granulomas were present in all cases without PN, but only in 3 of 8 cases with PN. Antimitochondrial antibody (AMA) was positive in all cases and anti-M2 was also positive in all but one. On the contrary, anti-M4 was positive in 2. Both anti-M2 and anti-M4 were simultaneously positive in 2, of which PN was present in only one. Therefore, anti-M4 did not relate to the presence or morphological severity of PN in PBC. Simultaneous increases in IgG and IgM were prominent features in PBC with PN.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707551     DOI: 10.1007/BF02774869

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  17 in total

1.  A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles.

Authors:  R B Beechey; S A Hubbard; P E Linnett; A D Mitchell; E A Munn
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

2.  THE PATHOLOGY OF PRIMARY BILIARY CIRRHOSIS WITH EMPHASIS ON HISTOGENESIS.

Authors:  A H BAGGENSTOSS; W T FOULK; H R BUTT; R C BAHN
Journal:  Am J Clin Pathol       Date:  1964-09       Impact factor: 2.493

3.  Immunological and histological studies in primary biliary cirrhosis.

Authors:  S Hadziyannis; P J Scheuer; T Feizi; R Naccarato; D Doniach; S Sherlock
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

Review 4.  Nonsuppurative destructive chronic cholangitis and chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  Prog Liver Dis       Date:  1970

5.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

6.  Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies.

Authors:  P A Berg; K H Wiedmann; T Sayers; G Klöppel; H Lindner
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

7.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

8.  Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; A H Baggenstoss; W H Summerskill
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

9.  Granulomas in primary biliary cirrhosis: a prognostic feature.

Authors:  R G Lee; O Epstein; H Jauregui; S Sherlock; P J Scheuer
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

10.  Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients.

Authors:  B Portmann; H Popper; J Neuberger; R Williams
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.